Skip to main content
Clinical Trials/NCT02691559
NCT02691559CompletedNot Applicable

The Possible Effect Of Amniotic Fluid pH On Neonatal Morbidities In Maternal Inflammation/Infection Associated Pregnancies

Kanuni Sultan Suleyman Training and Research Hospital1 site in 1 country184 target enrollmentStarted: August 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
184
Locations
1
Primary Endpoint
A total of 200 amniotic fluid (1ml per one) would be collected and analyzed for the study.

Study Overview

Brief Summary

Amniotic fluid (AF) pH can be affected by the maternal and/or fetal conditions such as PPROM, prematurity or fetal distress. It is known that fetal urine is the major content of AF since 20th gestational week. Besides fetal alveolar fluid (FAF), gastrointestinal tract, umbilical cord and fetal side of placenta are important sources for AF. Bombesin-like peptides, 8-hydroxydeoxyguanosine in fetal urine and leukotriene E(4), lecithin, sphingomyelin, lamellar body in FAF are molecules acting on fetal lung maturation. Varying levels of these molecules relevant to the stage of lung maturation may constitute an association to AF pHTo detect the possible effect of AF pH on neonatal respiratory morbidities 1 milliliters of AF is aspirated during C-section before incision of membranes. pH value of AFs were analyzed by the blood gas machine (Siemens RAPIDLab®1200 Systems) of NICU. Maternal and neonatal demographic features and clinical outcomes, incidences of morbidities such as respiratory distress syndrome (RDS), transient tachypnea of the newborn (TTN) are all recorded.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
— to 5 Minutes (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Inflammation/infection associated pregnancies Normal healthy pregnancies

Exclusion Criteria

  • Congenital abnormalities Chromosomal abnormalities Blood contaminated amniotic fluid

Outcomes

Primary Outcomes

A total of 200 amniotic fluid (1ml per one) would be collected and analyzed for the study.

Time Frame: through study completion, an average of 8 months

Amniotic fluid will be analysed for the value of its pH

Secondary Outcomes

  • A total of 200 amniotic fluid (1ml per one) would be collected and analyzed for the study.(through study completion, an average of 8 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Seda Yilmaz Semerci

Fellowship of Neonatology

Kanuni Sultan Suleyman Training and Research Hospital

Study Sites (1)

Loading locations...

Similar Trials